TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33591137

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block (QLB)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Epidural block (EB)
Number of subjects: 72
Study: 32361367

Group type: EXPERIMENTAL
Intervention: Text-based Scheduled Gradual Reduction (SGR) intervention
Number of subjects: 98

Group type: COMPARATOR
Intervention: Text-based support messages only (Control)
Number of subjects: 98
Study: 35972218

Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 13026

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13026
Study: 33225983

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (5-day treatment)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 33693713

Group type: EXPERIMENTAL
Intervention: Vitamin D3 4000 IU daily
Number of subjects: 2385

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2385
Study: 32932868

Group type: EXPERIMENTAL
Intervention: self-reported no-missed urine
Number of subjects: 2143

Group type: EXPERIMENTAL
Intervention: creatinine index ≥0.7
Number of subjects: 2143

Group type: EXPERIMENTAL
Intervention: mCER within 25% Kawasaki predicted urine creatinine
Number of subjects: 2143

Group type: EXPERIMENTAL
Intervention: mCER within 15% Kawasaki predicted urine creatinine
Number of subjects: 2143

Group type: EXPERIMENTAL
Intervention: sex-specific mCER ranges
Number of subjects: 2143
Study: 35869615

Group type: EXPERIMENTAL
Intervention: Cylindrical abutment
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Concave abutment
Number of subjects: 25
Study: 33630639

Group type: EXPERIMENTAL
Intervention: Behavioral treatment with an emphasis on exercise (BT + PA)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Acceptance-based treatment with an emphasis on exercise (ABT + PA)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard behavioral treatment (BT)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Higher levels of MVPA
Number of subjects: 320
Study: 35812198

Group type: EXPERIMENTAL
Intervention: Repetitive sacral root magnetic stimulation (rSMS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transcutaneous posterior tibial nerve stimulation (TTNS)
Number of subjects: 50
Study: 32124707

Group type: EXPERIMENTAL
Intervention: Connection Project intervention
Number of subjects: 610
Study: 35309176

Group type: EXPERIMENTAL
Intervention: Humanoid robot supervision of stretching exercises
Number of subjects: 27

Group type: COMPARATOR
Intervention: Physiotherapist supervision of stretching exercises (control)
Number of subjects: 27
Study: 32340276

Group type: EXPERIMENTAL
Intervention: k‐Nearest Neighbors (kNN)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Support Vector Machines (SVM)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Neural Networks (NN)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Blind source separation employing independent component analysis (ICA)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Welch's method, autoregressive modeling, and discrete wavelet transform
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Principal component analysis (PCA)
Number of subjects: 17
Study: 35396952

Group type: EXPERIMENTAL
Intervention: Intensive exercise therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non-intensive exercise therapy
Number of subjects: 44
Study: 32340479

Group type: EXPERIMENTAL
Intervention: Similarity visual juxtaposition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison juxtaposition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual juxtapositions (all types)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levels of surprise
Number of subjects: 0
Study: 34768315

Group type: EXPERIMENTAL
Intervention: Causal mediation analysis (CMA)
Number of subjects: 0
Study: 33856424

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (active stimulation)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 66
Study: 36043965

Group type: COMPARATOR
Intervention: F4 patch
Number of subjects: 54

Group type: COMPARATOR
Intervention: F3 patch
Number of subjects: 54
Study: 34774093

Group type: EXPERIMENTAL
Intervention: Group-based trauma-focused programme (Teaching Recovery Techniques), delivered by mental health practitioners both online and in-person
Number of subjects: 50

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 50
Study: 35360941

Group type: EXPERIMENTAL
Intervention: Surgical treatment (117 hips, 36.4% of cases)
Number of subjects: 371

Group type: COMPARATOR
Intervention: Non-surgical treatment (remaining hips)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Patient-reported outcome measures (PROMs)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Late reossification stage (227 hips)
Number of subjects: 371
Study: 33582379

Group type: EXPERIMENTAL
Intervention: ERAS protocol (Intervention Group - IG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional recovery protocol (Control Group - CG)
Number of subjects: 120
Study: 32659480

Group type: EXPERIMENTAL
Intervention: Voice treatment with physiologic voice therapy plus vocal hygiene program (n=20)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Vocal hygiene program only (n=14)
Number of subjects: 34
Study: 35995769

Group type: EXPERIMENTAL
Intervention: Decitabine (DAC) + All-trans retinoic acid (ATRA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Decitabine (DAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: All-trans retinoic acid (ATRA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DAC + ATRA
Number of subjects: 0
Study: 32562650

Group type: EXPERIMENTAL
Intervention: sulfadoxine‐pyrimethamine
Number of subjects: 1617

Group type: COMPARATOR
Intervention: dihydroartemisinin‐piperaquine
Number of subjects: 1617
Study: 34179981

Group type: EXPERIMENTAL
Intervention: TAVI
Number of subjects: 280

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 280
Study: 32649405

Group type: EXPERIMENTAL
Intervention: Total Cosine R to T (TCRT) analysis in FMF patients
Number of subjects: 56

Group type: COMPARATOR
Intervention: Total Cosine R to T (TCRT) analysis in control subjects
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Corrected average TCRT for heart rate in FMF patients
Number of subjects: 56

Group type: COMPARATOR
Intervention: Corrected average TCRT for heart rate in control subjects
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Follow-up of FMF patients
Number of subjects: 56
Study: 35277400

Group type: EXPERIMENTAL
Intervention: Drug-coating balloon (DCB) angioplasty
Number of subjects: 784

Group type: COMPARATOR
Intervention: Non-compliant balloon angioplasty
Number of subjects: 784
Study: 36179423

Group type: EXPERIMENTAL
Intervention: Reflective learning based on visual mind mapping
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional reflective journal
Number of subjects: 80
Study: 33711963

Group type: COMPARATOR
Intervention: Decompressive craniectomy (DC)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: DC plus head surface cooling (DCSC)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: DC plus endovascular hypothermia (DCEH)
Number of subjects: 34
Study: 32036562

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1.5 mA for 20 min)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (1.5 mA for 20 min)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA for 20 min)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2 mA for 20 min)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 102
Study: 36510110

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention framed around the DOAC checklist, including three educational clinical pharmacist tele-visits, hotline access to the pharmacist, and coordination with continuity providers over 3 months.
Number of subjects: 561

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 561
Study: 34491647

Group type: EXPERIMENTAL
Intervention: Combined treatment with fire needling therapy and acupoint application therapy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Acupoint application therapy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Western medication with pinaverium bromide tablets
Number of subjects: 150
Study: 32787824

Group type: EXPERIMENTAL
Intervention: Menopause Rating Scale (MRS)
Number of subjects: 330
Study: 36385642

Group type: EXPERIMENTAL
Intervention: Milrinone infusion for up to 35 hours
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal saline infusion (placebo) for up to 35 hours
Number of subjects: 9
Study: 34778188

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus nab-paclitaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nab-paclitaxel
Number of subjects: 0
Study: 32940404

Group type: EXPERIMENTAL
Intervention: Sumac (3 g/day) with restricted calorie diet (RCD)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo with restricted calorie diet (RCD)
Number of subjects: 62
Study: 35354633

Group type: EXPERIMENTAL
Intervention: Metformin added to usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 32219407

Group type: EXPERIMENTAL
Intervention: Improved basic preventive measures (sustained improvements in perioperative hand hygiene, vascular care, environmental cleaning, and patient decolonization efforts)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Improved basic preventive measures
Number of subjects: 236

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 236
Study: 36272891

Group type: EXPERIMENTAL
Intervention: MET + EMA
Number of subjects: 68

Group type: COMPARATOR
Intervention: MET-only
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Momentary MAA
Number of subjects: 68
Study: 33399374

Group type: EXPERIMENTAL
Intervention: 48 mg dexamethasone
Number of subjects: 64

Group type: COMPARATOR
Intervention: 8 mg dexamethasone
Number of subjects: 64
Study: 34653576

Group type: EXPERIMENTAL
Intervention: ACB + IPACK block
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ACB
Number of subjects: 120

Group type: COMPARATOR
Intervention: IPACK block
Number of subjects: 120
Study: 32931791

Group type: EXPERIMENTAL
Intervention: TETRA exposure at 6 W/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GSM900 exposure at 2 W/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 60
Study: 35188584

Group type: EXPERIMENTAL
Intervention: Combined hand exercise intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 33608735

Group type: EXPERIMENTAL
Intervention: In Vivo (experiential approach with sampling of NRTs)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Gold standard smoking cessation treatment (behavioral counseling plus self-selected combination NRT)
Number of subjects: 83
Study: 32815832

Group type: EXPERIMENTAL
Intervention: Standard CT (120 kV)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intermediate CT (100 kV)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-dose CT (80 kV)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All CT protocols
Number of subjects: 8
Study: 35248270

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) of the temporomandibular joint (TMJ)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Molar shim (MS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 20
Study: 32917495

Group type: EXPERIMENTAL
Intervention: Red kidney beans
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pinto beans
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Black beans
Number of subjects: 8

Group type: COMPARATOR
Intervention: Navy beans
Number of subjects: 8

Group type: COMPARATOR
Intervention: Rice
Number of subjects: 8
Study: 32510737

Group type: EXPERIMENTAL
Intervention: IL-6 measurement at 2 months in ARISTOTLE trial
Number of subjects: 7389

Group type: EXPERIMENTAL
Intervention: IL-6 measurement at 3 months in RE-LY trial
Number of subjects: 7389

Group type: EXPERIMENTAL
Intervention: IL-6 measurement at study entry and at 2 months in ARISTOTLE trial
Number of subjects: 7389

Group type: EXPERIMENTAL
Intervention: IL-6 measurement at study entry, 3, 6, and 12 months in RE-LY trial
Number of subjects: 7389
Study: 35172859

Group type: EXPERIMENTAL
Intervention: Abatacept and/or Methotrexate (treatment withdrawal)
Number of subjects: 172
Study: 33044440

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 32419117

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐Up (ABC) intervention
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Foster care placement
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Parenting intervention
Number of subjects: 211
Study: 35956305

Group type: EXPERIMENTAL
Intervention: Warning label (octagon with 'High in [nutrient]')
Number of subjects: 2869

Group type: EXPERIMENTAL
Intervention: Traffic light label
Number of subjects: 2869

Group type: EXPERIMENTAL
Intervention: Guideline Daily Amount (GDA)
Number of subjects: 2869

Group type: EXPERIMENTAL
Intervention: Health Star Rating (HSR)
Number of subjects: 2869

Group type: COMPARATOR
Intervention: Control label (barcode)
Number of subjects: 2869
Study: 33853187

Group type: EXPERIMENTAL
Intervention: ME-RP group
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: no-ME-RP group
Number of subjects: 43
Study: 35470087

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB) with multimodal analgesia
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (standard postoperative multimodal analgesia)
Number of subjects: 86
Study: 33165249

Group type: EXPERIMENTAL
Intervention: Medical adhesive treatment after debridement without local anesthesia
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group treatment with debridement, local anesthesia, and suture technique without medical adhesive
Number of subjects: 180
Study: 35421491

Group type: EXPERIMENTAL
Intervention: Poultry management training program
Number of subjects: 609
Study: 32748649

Group type: EXPERIMENTAL
Intervention: Daily/near-daily cannabis use
Number of subjects: 119

Group type: COMPARATOR
Intervention: No cannabis use
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Less-frequent cannabis use
Number of subjects: 119
Study: 36130180

Group type: EXPERIMENTAL
Intervention: Daily positive events reported on 83% of days
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Daily negative events reported on 56% of days
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACEs)
Number of subjects: 200
Study: 34217029

Group type: EXPERIMENTAL
Intervention: Start-Up NurseS program (4 weeks duration)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study: 32195930

Group type: EXPERIMENTAL
Intervention: SWJQD combined with acupuncture
Number of subjects: 81

Group type: COMPARATOR
Intervention: SWJQD combined with sham acupuncture
Number of subjects: 81

Group type: COMPARATOR
Intervention: metformin
Number of subjects: 81
Study: 35507047

Group type: EXPERIMENTAL
Intervention: CSP with EverLift™
Number of subjects: 291

Group type: COMPARATOR
Intervention: CSP without EverLift™
Number of subjects: 291
Study: 32776101

Group type: EXPERIMENTAL
Intervention: glo THP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking cessation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Never-smokers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continued smoking
Number of subjects: 0
Study: 33955250

Group type: EXPERIMENTAL
Intervention: Standard treatment plus proprioceptive training program
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 12
Study: 616848737

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (HEP) using a motion capture gerontechnology for 12 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (CONTR) continuing with discharge plan from ED
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (HEP)
Number of subjects: 16
Study: 35429293

Group type: EXPERIMENTAL
Intervention: Watermelon juice concentrate (WM; 2.2 g·day‐1 L‐citrulline)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 15
Study: 34078638

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) for 12 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 72
Study: 35715774

Group type: EXPERIMENTAL
Intervention: Alendronate sodium plus vitamin D3
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32592568

Group type: EXPERIMENTAL
Intervention: General hydrogalvanic baths
Number of subjects: 84

Group type: COMPARATOR
Intervention: Drug treatment (NSAIDs, muscle relaxants, anticonvulsants)
Number of subjects: 84
Study: 35942522

Group type: EXPERIMENTAL
Intervention: Mesalazine 2400 mg once-daily for 8 weeks
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Meta-analysis of mesalazine
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Mucosal patch technology measures
Number of subjects: 181
Study: 33742604

Group type: EXPERIMENTAL
Intervention: SPEM curriculum (experimental group)
Number of subjects: 3734

Group type: COMPARATOR
Intervention: Comparison curriculum (control group)
Number of subjects: 3734
Study: 36004652

Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32155470

Group type: EXPERIMENTAL
Intervention: Mindlight (experimental condition)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Triple Town (control condition)
Number of subjects: 109
Study: 32049691

Group type: EXPERIMENTAL
Intervention: PCD-CT VMIs at 50 keV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DE VMIs
Number of subjects: 0

Group type: COMPARATOR
Intervention: SE images
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCD-CT
Number of subjects: 0

Group type: COMPARATOR
Intervention: SE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DE
Number of subjects: 0
Study: 36032032

Group type: EXPERIMENTAL
Intervention: Pre-incision intra-articular injection of 10 mL ropivacaine with epinephrine and 20 mL post-arthrotomy peri-articular injection (PAI)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard 30 mL post-arthrotomy PAI of ropivacaine with epinephrine
Number of subjects: 41
Study: 34416469

Group type: EXPERIMENTAL
Intervention: Panitumumab plus FOLFOX followed by panitumumab-based maintenance
Number of subjects: 0
Study: 36059939

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate microspheres 3.75 mg (T)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Enantone® 3.75 mg (R)
Number of subjects: 48
Study: 32833578

Group type: EXPERIMENTAL
Intervention: Scaling and Root Planing with Photobiomodulation (PBMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP) without PBMT (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (SRP with PBMT and SRP without PBMT)
Number of subjects: 0
Study: 616897251

Group type: EXPERIMENTAL
Intervention: Heat application (2 minutes under servo-controlled mode at 35.5°C, followed by 2 minutes in manual mode at 100% power)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (radiant warmer at 35.5°C for 4 minutes)
Number of subjects: 40
Study: 34022474

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation + Exercise (CR + E)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cognitive Remediation Only (CR-Only)
Number of subjects: 34
Study: 32534921

Group type: EXPERIMENTAL
Intervention: Maternal colostrum (MC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Low-quality maternal colostrum supplemented with colostrum replacer (CR)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Colostrum replacer (CR) with distinct levels of IgG concentration
Number of subjects: 44
Study: 34264737

Group type: EXPERIMENTAL
Intervention: Harm-reduction treatment for alcohol use disorder (AUD)
Number of subjects: 294
Study: 32645160

Group type: EXPERIMENTAL
Intervention: Gender-affirming treatment
Number of subjects: 7770

Group type: COMPARATOR
Intervention: Other groups (not receiving gender-affirming treatment)
Number of subjects: 7770
Study: 37166567

Group type: EXPERIMENTAL
Intervention: 2 μg ID93 + 5 μg GLA-SE
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 10 μg ID93 + 5 μg GLA-SE
Number of subjects: 107

Group type: COMPARATOR
Intervention: 0.9% normal saline placebo
Number of subjects: 107
Study: 34219013

Group type: EXPERIMENTAL
Intervention: Body pillow position (group B)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Previous position using the arm fixation device (group A)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 85
Study: 32004636

Group type: EXPERIMENTAL
Intervention: OLZ/SAM (10/10 mg on days 2-4, 20/20 mg on days 5-8, 30/30 mg on days 9-13)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: OLZ/SAM (all doses)
Number of subjects: 100
Study: 35914240

Group type: EXPERIMENTAL
Intervention: Induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Expectant Management
Number of subjects: 0
Study: 32691466

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitor (PPI) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-reflux surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical therapy (including H2 receptor antagonists, alginates, baclofen, antidepressants)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endoscopic techniques
Number of subjects: 0
Study: 32353962

Group type: EXPERIMENTAL
Intervention: MgCl2 (ReMag®, 300 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 35067237

Group type: EXPERIMENTAL
Intervention: Dietary treatment for weight loss
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Exercise treatment
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 68

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 68
Study: 34011587

Group type: EXPERIMENTAL
Intervention: Home management
Number of subjects: 203

Group type: COMPARATOR
Intervention: Hospital management
Number of subjects: 203